XML 50 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Employee Benefit Plans (Tables)
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Stock-based compensation expense is included on the Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) based upon the job functions of the employees receiving the grants.  Compensation expense related to EOG's stock-based compensation plans for the years ended December 31, 2022, 2021 and 2020 was as follows (in millions):
 202220212020
Lease and Well$40 $49 $52 
Gathering and Processing Costs4 3 1 
Exploration Costs15 20 21 
General and Administrative74 80 72 
Total$133 $152 $146 
Schedule of Vesting
The vesting schedules for grants of stock options, SARs, restricted stock and restricted stock units, and Performance Units are generally as follows:
Grant TypeVesting Schedule
Stock Options/SARsVesting in increments of one-third on each of the first three anniversaries, respectively, of the date of grant
Restricted Stock/Restricted Stock Units
"Cliff" vesting three years from the date of grant
Performance Units
"Cliff" vesting on the February 28th following the three-year performance period and the Compensation and Human Resources Committee's certification of the applicable performance multiple
Schedule of Weighted Average Fair Values and Valuation Assumptions
Weighted average fair values and valuation assumptions used to value stock option, SAR and ESPP grants for the years ended December 31, 2022, 2021 and 2020 were as follows:
 Stock Options/SARsESPP
 202220212020202220212020
Weighted Average Fair Value of Grants
$28.30 $24.92 $11.06 $26.62 $18.12 $19.14 
Expected Volatility42.20 %42.24 %44.47 %43.00 %51.27 %53.48 %
Risk-Free Interest Rate0.89 %0.50 %0.21 %1.30 %0.07 %0.90 %
Dividend Yield3.28 %2.26 %3.27 %2.89 %2.89 %2.27 %
Expected Life5.3 years5.2 years5.2 years0.5 years0.5 years0.5 years
Schedule of Share Based Compensation Arrangement By Share Based Payment Award
The following table sets forth the stock option and SAR transactions for the years ended December 31, 2022, 2021 and 2020 (stock options and SARs in thousands):
 202220212020
 Number
of Stock
Options/
SARs		Weighted
Average
Grant
Price		Number
of Stock
Options/
SARs		Weighted
Average
Grant
Price		Number
of Stock
Options/
SARs		Weighted
Average
Grant
Price
Outstanding at January 19,969 $84.37 10,186 $84.08 9,395 $94.53 
Granted2 97.64 1,982 81.68 1,996 37.63 
Exercised (1)
(5,526)89.70 (1,130)63.98 (23)69.59 
Forfeited(220)82.74 (1,069)98.15 (1,182)88.93 
Outstanding at December 314,225 77.49 9,969 84.37 10,186 84.08 
Stock Options/SARs Exercisable at December 31
2,462 84.53 6,197 95.33 6,343 96.41 
(1)The total intrinsic value of stock options/SARs exercised during the years 2022, 2021 and 2020 was $190 million, $27 million and $0.4 million, respectively.  The intrinsic value is based upon the difference between the market price of the Common Stock on the date of exercise and the grant price of the stock options/SARs.
Schedule of Stock Options and SARs Outstanding and Exercisable
The following table summarizes certain information for the stock options and SARs outstanding and exercisable at December 31, 2022 (stock options and SARs in thousands):
Stock Options/SARs OutstandingStock Options/SARs Exercisable
Range of
Grant
Prices		Stock
Options/
SARs		Weighted
Average
Remaining
Life
(Years)		Weighted
Average
Grant
Price
 
 
Aggregate
Intrinsic
Value(1)
Stock
Options/
SARs		Weighted
Average
Remaining
Life
(Years)		Weighted
Average
Grant
Price
 
 
Aggregate
Intrinsic
Value (1)
$ 34.00 to $ 52.99
1,029 4$37.52  466 4$37.51   
53.00 to     80.99
593 374.98  584 375.04   
   81.00 to     81.99
1,513 681.81  331 581.81   
   82.00 to     96.99
562 195.62  553 195.75   
   97.00 to   129.99
528 3126.51  528 3126.53   
 4,225 477.49 $220 2,462 384.53 $111 
(1)Based upon the difference between the closing market price of the Common Stock on the last trading day of the year and the grant price of in-the-money stock options and SARs, in millions.
Schedule of ESPP Activity The following table summarizes ESPP activity for the years ended December 31, 2022, 2021 and 2020 (in thousands, except number of participants):
 202220212020
Approximate Number of Participants1,969 2,036 2,063 
Shares Purchased201 316 377 
Aggregate Purchase Price$17,250 $17,224 $16,103 
Schedule of Restricted Stock and Restricted Stock Unit Transactions
The following table sets forth the restricted stock and restricted stock unit transactions for the years ended December 31, 2022, 2021 and 2020 (shares and units in thousands):
 202220212020
 Number of Shares and UnitsWeighted Average Grant Date Fair ValueNumber of Shares and UnitsWeighted Average Grant Date Fair ValueNumber of Shares and UnitsWeighted Average Grant Date Fair Value
Outstanding at January 14,680 $69.37 4,742 $74.97 4,546 $90.16 
Granted1,637 113.21 1,422 81.50 1,488 38.10 
Released (1)
(2,019)81.76 (1,388)101.00 (1,213)85.92 
Forfeited(185)68.89 (96)68.26 (79)86.52 
Outstanding at December 31 (2)
4,113 80.77 4,680 69.37 4,742 74.97 
(1)
(1)The total intrinsic value of restricted stock and restricted stock units released during the years ended December 31, 2022, 2021 and 2020 was $223 million, $110 million and $48 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date restricted stock and restricted stock units are released.
(2)
(2)The total intrinsic value of restricted stock and restricted stock units outstanding at December 31, 2022, 2021 and 2020 was $533 million, $416 million and $236 million, respectively. The intrinsic value is based on the closing market price of the Common Stock on the last trading day of the year.
Schedule of Weighted Average Fair Values and Valuation Assumptions for Performance Units/Stocks Weighted average fair values and valuation assumptions used to value Performance Units during the years ended December 31, 2022, 2021 and 2020 were as follows:
 202220212020
Weighted Average Fair Value of Grants$126.55 $95.16 $42.77 
Expected Volatility56.11 %53.80 %47.27 %
Risk-Free Interest Rate4.01 %0.59 %0.16 %
Schedule of Performance Unit and Performance Stock Transactions
The following table sets forth the Performance Unit transactions for the years ended December 31, 2022, 2021 and 2020 (units in thousands):
 202220212020
 Number of UnitsWeighted Average Grant Date Fair ValueNumber of UnitsWeighted Average Grant Date Fair ValueNumber of UnitsWeighted Average Grant Date Fair Value
Outstanding at January 1679 $84.97 613 $88.38 598 $103.91 
Granted122 126.55 222 95.16 172 42.77 
Granted for Performance Multiple (1)
— — 19 113.81 66 119.10 
Released (2)
(57)136.74 (175)113.06 (223)103.87 
Forfeited for Performance Multiple (3)
(56)136.74 — — — — 
Outstanding at December 31 (4)
688 (5)83.82 679 84.97 613 88.38 
(1)Upon completion of the performance period for the Performance Units granted in 2017 and 2016, a performance multiple of 125% and 150%, respectively, was applied to each of the grants resulting in additional grants of Performance Units in February 2021 and 2020.
(2)The total intrinsic value of Performance Units released during the years ended December 31, 2022, 2021 and 2020 was $7 million, $13 million and $13 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date Performance Units are released.
(3)Upon completion of the performance period for the Performance Units granted in 2018, a performance multiple of 50% was applied to the grants resulting in a forfeiture of Performance Units in February 2022.
(4)The total intrinsic value of Performance Units outstanding at December 31, 2022, 2021 and 2020 was $89 million, $60 million and $31 million, respectively. The intrinsic value is based on the closing market price of the Common Stock on the last trading day of the year.
(5)Upon the application of the relevant performance multiple at the completion of each of the remaining performance periods, a minimum of zero and a maximum of 1,376 Performance Units could be outstanding.